The startup develops pathogen identification devices that utilize a combination of molecular and immunological techniques for sepsis diagnostics, achieving high sensitivity and accuracy in pathogen detection. This technology enables medical professionals to diagnose infections early, significantly improving patient recovery outcomes.
Funding
$640K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Sepsis diagnosis relies on blood culture, a process that can take several days to yield results. This delay hinders prompt and targeted treatment, leading to increased mortality rates as broad-spectrum antibiotics are used while awaiting specific pathogen identification. Rapid identification of the causative pathogens is crucial to improve patient outcomes and reduce the overuse of broad-spectrum antibiotics.
Solution
Nanological offers SOMIA, a diagnostic platform for rapid sepsis detection directly from whole blood, eliminating the need for traditional culture methods or sample labeling. Utilizing optomechanical sensing and AI-powered algorithms, SOMIA analyzes individual cells based on mass, size, and optical absorbance to identify pathogens within minutes. The platform's integrated microfluidics automate sample preparation, isolating bacteria from the blood sample. By providing fast and accurate pathogen identification, SOMIA enables clinicians to initiate targeted treatment sooner, potentially increasing patient survival rates and optimizing antibiotic usage.
Target Audience
The primary target audience includes clinical laboratories and healthcare providers, specifically those in hospitals and acute care settings, who require rapid and accurate sepsis diagnostics for timely treatment decisions.
Features
- Optomechanical biosensing technology for analyzing cells based on mass, size, and optical absorbance
- AI-powered algorithms for pathogen identification with high sensitivity and specificity
- Integrated microfluidics for automated sample preparation and bacteria isolation from whole blood
- Culture-free and label-free pathogen identification process
- Results available in under 30 minutes
- Compact and easy-to-use design for point-of-care diagnostics
- Disposable cartridge for easy sample insertion